The Spot Sign for Predicting and Treating ICH Growth Study
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if computed tomography angiography can predict
which individuals with intracerebral hemorrhage will experience significant growth in the
size of the hemorrhage. For individuals who are at high risk for hemorrhage growth, the study
will compare the drug recombinant activated factor VII (rFVIIa) to placebo to determine the
effect of rFVIIa on intracerebral hemorrhage growth.
Phase:
Phase 2
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)